Asset Planning Services Inc Eli Lilly & CO Transaction History

Asset Planning Services Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Oct 13, 2020	SELL	$146.22 - $169.13 $346,541 - $400,838	-2,370 Closed	0 $0
Q4 2018 Jan 24, 2019	BUY	$105.9 - $118.64 $4,765 - $5,338	45 Added 1.94%	2,370 $274,000
Q3 2018 Nov 06, 2018	BUY	$85.86 - $107.31 $199,624 - $249,495	2,325 New	2,325 $0
Q1 2018 Apr 17, 2018	SELL	$74.21 - $87.6 $3.66 Million - $4.32 Million	-49,295 Closed	0 $0
Q4 2017 Jan 25, 2018	BUY	$81.94 - $87.89 $45,067 - $48,339	550 Added 1.13%	49,295 $4.16 Million
Q3 2017 Nov 13, 2017	BUY	$77.07 - $85.54 $57,802 - $64,155	750 Added 1.56%	48,745 $4.17 Million
Q2 2017 Aug 08, 2017	BUY	N/A	47,995	47,995 $3.95 Million

3,913

765M

6.34M

7.96M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $766B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Asset Planning Services Inc , based on Form 13F filings with the SEC.

Stay updated on Asset Planning Services Inc with notifications on news.